Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...
Maryam, 51, refrained from detailing her health condition, stating only that her treatment is progressing. Before heading to Switzerland ... Public concern intensified, but Senior Punjab Minister ...
Learn about MSK’s active surveillance program for papillary thyroid cancer, which allows many people to avoid unnecessary surgery and the risks that come with it.
These actions can also be observed in patients taking other currently used cholesterol-lowering drugs, such as statins. Selective thyroid hormone receptor modulation is a promising new strategy ...